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Although it was previously generally accepted that the immunoglobulin recep-
tors on B lymphocytes were directly responsible for at least the initial steps in
lymphocyte activation, the findings that thymus-independent antigens were at
the same time polyclonal B-cell activators (PBA),' capable of inducing poly-
clonal antibody synthesis in high concentrations (7), lead to the realization that
at least one triggering receptor is not the immunoglobulin receptor (5, 6) .
Actually, most of the available evidence suggests that Ig receptors do not activate
B cells, although they possess a passive focussing function, allowing them to
selectively concentrate to their surface the activating signals present on TI
molecules or secreted by accessory cells (6, 8, 9) . The evidence for this one
nonspecific signal hypothesis (9) can be summarized as follows .
Haptens coupled to PBA induce specific TI responses at low concentrations and
polyclonal activation at high concentrations, which cause paralysis of the specific
antihapten response (5, 6) . Free hapten does not prevent induction of antihapten or
polyclonal responses induced by hapten-PBA conjugates, indicating that Ig receptors do
not by themselves deliver paralytogenic signals, but free hapten prevents induction of
specific antihapten responses by low (but not high) conjugate concentrations, indicating
that the Ig receptors function to focus the triggering signal to the B cells (5, 6) .
Subthreshold concentrations of hapten-PBA conjugates added to B cells together with low
concentrations of unsubstituted PBA cause a specific antihapten response (footnote 2),
which could not be induced by any substance alone, suggesting that triggering was
provided both by the carrier and the hapten-PBA conjugate and that these worked
additively in the induction of specific antihapten responses . In addition, immune
responses induced by PBA could never be suppressed by the addition of free TD-antigen or
hapten, showing that the Ig receptors neither induced nor prevented induction by
competent stimuli (5, 28), whereas haptenic molecules for PBA, such as low molecular
weight dextrans, effectively suppressed induction of specific and polyclonal antibody
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synthesis (6, 8), because they interfered with the correct (non-1g) triggering sites at the
cell surface .
Several lines of evidence suggest that Ig receptors by themselves are not the triggering
structures . Thus, attempts to induce specific antibody synthesis to haptens and hapten
(TD) protein conjugates by adding them to lymphocytes in soluble or precipitated form or
by fixing the antigens onto nonmitogenic matrixes, such as Sepharose particles, have
failed, although the same haptens coupled to PBA carriers always induced specific
synthesis (28) . Clearly, the carrier and not the hapten (or the hapten density) was
primarily responsible for induction of antibody synthesis, and the carriers differed with
regard to their PBA properties, the protein carriers used completely lacking PBA
properties . This is further supported by findings using protein carriers having PBA
properties (KLH) coupled to insoluble matrixes (15) which were immunogenic in vitro .
The final evidence comes from studies on genetic nonresponders to a PBA (lipopolysac-
charide [LPS ]) . The strain C3H/HeJ is resistant to the toxic effects of LPS and does not
respond with polyclonal antibody synthesis to LPS (34) . This defect is a property of the B
cells . The C3H/HeJ mice fail to mount a specific immune response to haptens coupled to
LPS, but not to the same or related haptens coupled to other PBA molecules or to
thymus-dependent antigens (33, 35, footnotes 3 and 4) . Thus, the V gene repertoire to the
antigens studied is normal in the animals, but they fail to produce antibodies because they
cannot respond to carrier delivering the triggering signal . This finding definitely rules out
Ig receptor-mediated triggering by itself and cannot be accomodated by any concept of Ig
cross-linking or receptor redistribution hypothesis . The genetic evidence also demon-
strates that PBA properties are necessary for immunogenicity and focus attention on the
nature of the non-Ig structures responsible for triggering of B cells .
As a first attempt to study the structures responsible for immunocyte triggering,
attention was focussed on already well characterized surface receptors, which
have been implicated in B-cell activation . These include the C'3 and Fc
receptors, in addition to the Ig receptors, the latter already being excluded . It has
been suggested that C'3 receptors are triggering structures, to a large extent
based on the finding that many, but not all PBA have the capacity to bypass the
normal sequence of complement fixation and are capable of directly activating
C'3 (13, 30) . Although different findings have been made regarding the role of C'3
receptors in TI and TD responses (12, 13, 16, 19, 30), it was considered important
to investigate carefully whether these receptors by themselves are competent to
activate B cells or whether they were capable of interfering with activation
induced by competent PBA .
The Fc receptors have also received attention as triggering structures, because
they may function as receptors for Ig (1, 10) and they appear to be in close
association with the la antigens on B cells, the latter structures being considered
to be of importance in lymphocyte activation (11, 14) . Therefore, studies were
executed to elucidate the role of Fc receptors in B-cell activation .
'Coutinho, A ., E. Gronowicz, and B . Sultzer . 1973 . Genetical control of B-cell responses : selective
unresponsiveness to lipopolysaccharide . Scand . J . Immunol. In press .
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Materials and Methods
Mice .
￿
Mice of the inbred strains A, B10.5M, CBA, and F, hybrids between these strains were
used in different experiments .
Mitogens . Lipopolysaccharide from Escherichia coli 055.135 prepared by the phenol-water
extraction method was obtained from Dr . T. Holme, Dept . of Bacteriology, Karolinska Institute,
Stockholm . Purified-protein derivative of tuberculin (PPD) was obtained from the State Serum
Institute, Copenhagen, Denmark as a preservative-free solution containing 1 mg/ml . Stearoyl-dex-
tran (S . Dex) (7 x 10' mot wt, 1 stearoyl group/20 glucose units) was obtained from Dr .W . Richter,
Pharmacia, Uppsala . Pneumococcal polysaccharide SIII was purchased from Burroughs Wellcome,
England, and obtained as a lyophilized powder . Dextran sulphate from Pharmacia Fine Chemicals,
Uppsala (5 x 10` mot wt, sulphur content 17%) was used in some experiments .
Preparation of Lymphocytes . Spleens were removed from mice, cut in pieces, and pressed
through a 60 mesh stainless steel screen into ice-cold balanced salt solution (BSS) . After brief
sedimentation, the cells in the supernates were washed three times in BSS and subsequently
suspended in culture medium to the desired cell concentration . Cellular and viability counts were
performed in Burker haemocytometers after staining the damaged cells with 0.02% trypan blue .
Medium . The medium used was Eagle's minimum essential medium in Earle's solution,
supplemented with glutamin, nonessential amino acids and pyruvate, and containing 100 IU of
penicillin and 100mg of streptomycin per ml, respectively, as described by Mishell and Dutton (24) .
The medium was further buffered by 10 mM of Hepes, and the pH adjusted to 7.0-7 .2 . All these
reagents were obtained from Flow Laboratories, Irvine, Scotland . Experiments were carried out in
serum-free medium or occasionally in the presence of 10% fetal calf serum (Rehatuin, batch 238) .
Assay ofDNA Synthesis .
￿
Cultures were given a 24-hr pulse of ['H ]thymidine (The Radiochemi-
cal Centre, Amersham, England) with a spec act of5Ci/mmol), diluted in culturemedium in order to
have a concentration of 2 kCi/ml in the cultures . Tube cultures were harvestedby pouring them onto
Sartorius membranes (0.8p pore size) in a Millipore multi-manifold sample collector . The cells were
washed in 15 ml of 0.9% saline and the filters placed in scintillation vials to dry overnight . 5 ml of
scintillation fluid was added to each vial and the samples counted in a scintillation spectrometer
(Tri-Garb Packard, Packard Instrument Co ., Downers Grove, Ill .) .
Lymphocyte Cultures .
￿
Induction of antibody synthesis was always performed in 3 cm diameter
plastic petri dishes (Nunc, Denmark) using a cell concentration of 10' spleen cells/ml/culture, set up
in triplicates . Cultures were incubated at 37 °C in plastic boxes filled with a mixture of 10% CO,, 83%
Nz and 7% O,, and rocked on a platform at 8 oscillations per minute .
Assay of Antibody Synthesis .
￿
A modification (4) of the Jerne plaque assay (19) was used to
quantitate cellular antibody production in culture . Cells harvested with a plastic policeman were
washed once in cold BSS and adjusted to the desired cell concentration . 0.6 ml of 0.5% agar (Difco
Bacto Agar, Difco Laboratories, Detroit, Mich .) in BSS containing 0.05% DEAE-dextran (Pharmacia
Fine Chemicals, Uppsala, Sweden) wasadded to haemolysis tubes, kept at 46°C . Thereafter, 0.05 ml
of the indicator red cells diluted 1:8 in BSS, 0.2 ml of the cell suspension and 0.05 ml of guinea pig
serum diluted in 1 :4 inBSS were added to each tube . The mixture was plated in three 0.2-ml spread
sports on plastic petri dishes of 9 cm diameter, and incubated for3 h at 37°C. Plaque-forming cells
were counted using indirect light .
Different red cells were used as indicators in the assay . Sheep red blood cells, always obtained from
the same donor, were stored in sterile alsever's solution and washed twice in BSS before use . For
haptenation of the red cells (using NNP or fluorescein isothiocyanate-FITC), extensively washed
sheep blood was suspended in a carbonate-bicarbonate buffer, pH 9.2 (20% vol/vol) and kept with
permanent stirring at room temperature . The reactive forms of the haptens were then added and the
reaction allowed to proceed for 40 min . The haptenated red cells were finally extensively washed and
used in theplaque assay . A concentration of0.1 mg/ml was used with NNP-acid and with FITC, the
concentration varied between 5 and 0.1 mg/ml depending on whether low or high affinity antibodies
should be detected .
Conjugation of FITC to Various Carriers .
￿
FITC (BDH Chemicals, Isomer no . 1) was conjugated
to proteins according to the method of Bergqvist and Schilling (2) . In short, FITC was dissolved in
bicarbonate buffer pH 9.23 . TheFITC concentrations ranged from 10 to 0 .1 mg/ml . 3.3 ml of theFITC
solutionswere enclosed in dialysis bags . Thebags were immersed into 10 ml ofHGGorHSAsolutions650
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containing 10 mg protein per ml. Theproteins used were previously dissolved in the same bicarbonate
buffer, pH 9.23. The mixture wasstirred overnight for 24 hat 0°C and thereafter the protein solution
wasadded to aSephadex G-25 column and eluted with phosphate buffer pH 7. Theprotein solutions
were filtered to sterility and made up to protein concentration of 2 mg/ml.
LPS could not be efficiently labeled by the above procedure and therefore the following method
was adopted. 10 mg/ml of LPS was dissolved in bicarbonate buffer pH 9.23 and in aseparate vessel 2
mg/ml of FITC were dissolved in the same buffer. To 1 ml LPS solution was added 3 ml of FITC
solution . The mixture was stirred overnight and LPS separated from nonreacted FITC by passage
through Sephadex G-25 column. For stronger labeling 20 mg of LPS was directly dissolved in 2 ml
FITC solution (10 mg/ml bicarbonate buffer, pH 9.23). The content of FITC per mole of protein or
LPS was kindly determined spectrophotometrically by Dr. R. Bergqvist according to the method of
McKinney et al. (22) . The following preparations were used (molar ratio of FITC to carrier)
FITC,e-HGG and FITC,e-LPS. In thecase ofLPS a molwt of 108 wasassumedfor the calculations.
Antisera.
￿
Antisera for the elaboration of Fe rosette-forming cells (RFC) was obtained from a
rabbit after 6wk intravenous injections of 1 ml of a 25% suspension of sheep redblood cells (SRBC).
The serum was separated on a Sephadex G-200 column (Pharmacia Fine Chemicals, Inc., Uppsala,
Sweden) and the 7S fraction was collected and concentrated to original serum volume by negative
pressure dialysis. A 19S fraction from a rabbit anti-SRBC antiserum was obtained from Dr. Knut
Lidman, National Bacteriology Laboratory, Stockholm, Sweden.
Antiserum to FITC was prepared by injecting mice with 400 gg alum-precipitated FITC,o-HGG
intraperitoneally four times at weekly intervals. The mice were bled 6 days after the last injection.
The serum was used unseparated or the 7S fraction after Sephadex G-200 was employed.
Determination of Fc-Binding Lymphocytes . In order to study the number of lymphocytes
capable ofbinding to the Fe portion of antibody molecules, the following procedure was followed (27) .
1 ml of SRBC (1%) was mixed with the 7S fraction of a rabbit anti-SRBC antibody so that thefinal
antiserum dilution was ''/,oo and incubated for 30 min at room temperature. Thereafter, the suspen-
sion was cooled in ice and washed three times in the cold. 0.1 ml of a 1% suspension of the antibody-
coated SRBC was added to 0.1 ml of a suspension of lymphocytes (25 x 10, cells/ml) and finally 0.5
ml BSSwasadmixed. The cells were centrifuged at 750 rpm in the cold and carefully resuspended by a
pasteur pipette, and the number of Fc rosettes wasdetermined in the microscope. When Fc-binding
cells were enumerated using FITC,e-HGG or FITC,e-LPS various concentrations of FITC-HGG (250
Rg/ml to 25 pg/ml) were mixed with different concentrations (undiluted to V16) of the antiserum for
30 min at 37°C and thereafter 108 lymphocytes were added to the mixture for another 30 min. After
three washings the number of fluorescent cells were counted. An analogous procedure was followed
with FITC,e-LPS although 2 mg/ml of the antigen was used with various concentrations of the 7S
fraction of the anti-FITC-HGG antiserum.
Determination of C'3-Binding Lymphocytes.
￿
In short, the following procedure was followed. 1 ml
of a 1% SRBC solution wastreated with arabbit anti-SRBC IgM preparation at afinal dilution of '/640
for 30 min at 37°C. The SRBC were then washed in the cold three times and resuspended to the
original volume. Subsequently, fresh strain A mouse serum as a source of complement, was added to
thesuspension at a final dilution of/. Thesuspension was incubated for another 30 min at 37°C, and
then the SRBC were again washed three times and diluted to 1% in BSS. The antiserum employed
did not cause RFC formation in the absence of added mouse sera as a source of complement.
Experimental Procedure.
￿
The experiments aimed at determining whether C'3 or Fc receptors
were directly involved in lymphocyte activation or could suppress activation induced by PBA. The
C'3 receptors were studied in two ways: lymphocytes (10'/ml) were treated with 100 Jug/ml of S. Dex
for 30 min at 37°C and thereafter washed extensively. Half of the cells were incubated with fresh
mouse serum as a source of complement (15 x 10' cells/ml in an equal volume of serum), or
heat-inactivated mouse serum (56°C for 45 min) or with BSS. The cells were again washed and
thereafter cultivated in serum-free medium in the presence or absence of PBA. In parallel, the ability
of the treated cells to bind Fc and C'3-coated SRBC was determined.
Asecond method to study the role of C'3 receptors was to incubate different PBA (2 mg/ml) with
fresh or heat-inactivated mouse serum (or in some experiments guinea pig serum as a source of
complement) or BSS. The PBA were then directly added to cells in Mishell-Dutton cultures and the
response determined 2 days later. Finally, mixtures of different concentrations of anti-FITC-HGG
and FITC,e-HGG (250 or 25 ug/ml) were treated with fresh or inactivated mouse serum or BSS andGORAN MULER AND ANTONIO COUTINHO
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added to Mishell-Dutton cultures in the presence or absence of PBA and the response again
determined 2 days later.
The role of Fe receptors were analyzed in an analogouswayusingmouseanti-FITCserumor the 7S
fraction of this serum and FITC,o-HGG or FITC,o-LPS. A mixture of these reagents was added to
cultured cells in the presence of PBA to determine whether the treated cells were activated to
polyclonal antibody synthesis or whether theresponse to PBA was altered.
A second method employed SRBC coated with the7S fraction of a rabbit anti-SRBC diluted I/loo or
'/.ooo as described above. The SRBC and lymphocytes were mixed in proportions as described for
theFc rosetteassay, centrifuged and carefully resuspended. The mixture was cultivated alone or with
LPS or PPD in serum-free cultures . Appropriate controls were included as will be described later.
Results
C'3 Receptors do not Activate Lymphocytes or Prevent their Triggering by
Different PBA. Stearoyl dextran binds to cell membranes and has the ability to
fix complement onto the cell membrane . This was demonstrated by first treating
SRBC with various concentrations of S. Dex, washing the cells three times, and
thereafter adding guinea pig serum as a source of complement . It was found that
red cells treated with S. Dex. (in concentrations from 1 mg/ml to 15 ug/ml) were
completely lysed by complement, whereas noncomplement treated red cells were
completely unaffected. Most likely the lipid part of the molecule dissolves in the
membrane and remains attached after extensive washing and thereafter S. Dex is
capable of binding complement, leading to lysis of the cells. Analogous studies
were made with lymphocytes. The degree of lysis after addition of guinea pig
complement was much smaller (35%). S. Dex itself had no toxic effect on
lymphocytes. These results demonstrate that S. Dex binds to lymphocytes and
red cells and these subsequently become capable of fixing guinea pig comple-
ment.
As a next step it was studied whether mouse complement would be fixed in an
analogous way. Since mouse serum is poorly lytic it was investigated whether
S. Dex treated mouse lymphocytes, subsequently mixed with mouse serum as a
source of complement would interfere with the ability of such cells to bind
C'3-coated red cells in a rosette assay. As can be seen in Table I this was the case,
TABLE I
Inhibition of C'3 Binding by Stearoyl Dextran and Fresh Mouse
Serum
Treatmentoflymphocytes*
RFC binding
Fe
￿
C'3
S. Dex plus BSS
￿
36
￿
29
S. Dex plus heat-inactivated serum
￿
36
￿
32
S. Dex plus freshserum
￿
40
￿
6
* 10' lymphocytes were incubated with 100 jug S. Dex for 10 min at room
temperature. After two washings the cells were incubated with BSS,
heat-inactivated or normal serum, respectively, for39 minat 37*C.After
threewashings the cells were rosetted with SRBC treated to reveal Fc or
C'3 binding lymphocytes .652
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whereas the binding of Fc-coated red cells was the same as in untreated cells .
Controls treated with heat-inactivated serum or with S . Dex alone did not inhibit
C'3 or Fc rosette formation .
Having established that the C'3 receptors indeed react with complement by
the procedure used it was investigated whether C'3 receptors could cause
activation of polyclonal antibody synthesis after having reacted with comple-
ment . As shown in Fig . 1 this was not the case . Thus, there was no increase in the
plaque-forming cell (PFC) response against FITC, NNP, or SRBC of lympho-
cytes treated with S . Dex alone or S. Dex and fresh mouse serum. Neither did
binding of C'3 to spleen cells prevent induction of polyclonal activation induced
by PBA, such as LPS or PPD (Fig . 1) . Thus, there was no evidence for a
triggering role of C'3 receptors nor was there any indication that the C'3 receptors
constituted part of the triggering receptors, since blocked C'3 receptors did not
interfere with PBA activation .
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Failure of C'3 receptors to activate lymphocytes or to prevent their activation byLPS
or PPD. Lymphocytes were untreated or treated in vitro with 1 mg of S. Dex or S . Dex plus
fresh mouseserum as a source of complement and thereafter cultivated in serum-free medium
for2days (0 ) . In addition, the cells were given 100AgLPS (®) orPPD (0) in culture andthe
polyclonal antibody response against FITC-SRC determined at day 2.
C'3 Receptors have a Passive Focusing Function in Lymphocyte Activation by
Competent Ligands . As already mentioned, several PBA have the capacity of
bypassing the normal sequence of complement fixation and directly activating
and binding C'3 . Actually this finding constituted thebasis forthe postulate that
C'3 receptors are responsible forlymphocyte activation . In order to studythe role
of C'3 in activation of lymphocytes by PBA the following types of experiments
were performed . PBA were mixedwith fresh mouseserum or guinea-pig serum as
sources of complement for 30 min at 37'C and thereafter various concentrations
of the mixtures were added to spleen cell cultures in serum-free medium and the
polyclonal antibody responses were measured 2 days later or, alternatively,
induction of DNA synthesis was determined 3 days later . Controls consisted of
PBA mixed with heat-inactivated serum, or with BSS . Several experiments were
carried out to study whether fresh and heat-inactivated serum had differential
effects onlymphocytes in culture, but it was not possible to show that with regardto cell survival, response to T mitogen, background antibody synthesis, induction
of primary antibody responses to SRBC .
Experiments were performed with LPS, SIII, PPD, and S . Dex and the results
were essentially similar with all of them . Thus, PBA incubated with normal
serum did not result in an increased number of PFC or greater degree ofDNA
synthesis, irrespective of whether the serum was heat-inactivated or not . On the
contrary, there was quite often a slight reduction of the total number ofPFC by
serum treatment as compared to the response after treatment with BSS,
although to a small extent only . However, fresh mouse serum-treated PBA
always caused a shift in the dose response profile as compared to PBA treated
with inactivated serum or with BSS . Thus, 10- to 100-fold lower concentrations of
the PBA resulted in optimal stimulation in the presence of fresh serum and there
was a distinct suppression of the response at concentrations which were optimal
in the presence ofBSS or heat-inactivated serum (Figs . 2-5) . Thesefindings were
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FIG. 2.
￿
LPS was mixed with fresh mouse serum (/-/), heat-inactivated serum (0-0) or
BSS (x-x) andthereafter different concentrations of the mixtures were added to spleen cells
in serum-free culture . In addition, the same concentrations of fresh (" . . .") or inactivated
(0 - - -p) serum were added alone to the cultures . The anti-FITC response was determined at
day 2 . The background response in untreated cultures is also shown (A).
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consistently made when normal mouse serum was the source of complement .
However, when guinea pig complement was employed, there was sometimes a
very weak induction of polyclonal antibody synthesis, presumably because of
complement-mediated toxic effects on the lymphocytes . In principle, the results
were analogous to those reported with mouse serum (Fig . 6) . Thus, PBA thathad
bound C'3 caused a shift in the dose response curve, lower concentrations of the
PBA being needed for optimal activation .
The effect of PBA complement complexes to decrease thePBA concentration
needed for optimal concentration is presumably due to afocussing function of the
C'3 receptors, which allows more PBA molecules that have bound C'3 to be fixed
to the lymphocytes at any PBA concentration . This interpretation is supported
by direct experiments demonstrating binding of FITC,o-LPS to lymphocytes in
the presence of fresh but not heat-inactivated mouse serum as a source of654
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FIG . 3 .
￿
PPD was mixed with fresh serum (O-O) heat-inactivated serum ("-8) or BSS
(x-x) and thereafter different concentrations of the mixtures were added to serum-free
cultures of spleen cells . The response against FITC was determined at day3 . The background
is also shown (A) .
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￿
Same as Fig . 3, except that SIII was used and that DNAsynthesiswas determined at
day 3.
complement . FITCIo-LPS was treated with fresh or inactivated mouse serum and
thereafter mixed with spleen cells and the number of cells binding to fluorescent
LPS was determined in a fluorescent microscope . It was found that FITC IO-LPS
incubated with fresh mouse serum fixed to about 35% of the lymphocytes,
whereas LPS incubated with heat-inactivated serum only bound to 2% . As a
second step it was investigated whether lymphocytes which had reacted with
fresh normal serum-treated LPS would be capable of bindingSRBC prepared to
reveal C'3 or Fc binding lymphocytes . The results (Table II) show that fresh
serum-treatedLPS completely abolished binding of C'3RFC, whereas LPS itself,
LPS treated with heat-inactivated serum or fresh serum itself did not have this
effect . Fe-binding lymphocytes were not significantly affected by any treatment .
It seems likely that the C'3 receptors will have a passive focussing role in
immunocyte triggering by PBA in the presence ofcomplement in the same way asN
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￿
Same as Fig. 4 using S. Dex.
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￿
Same as Fig. 5, but using LPS, measuring polyclonal antibody synthesis and using
guinea pig serum as a source of complement.
TABLE II
Inhibition of C'3 Binding by LPS and Fresh Mouse Serum
* LPS (2 mg/ml) was first mixed with an equal vol of BSS, heat-inac-
tivated or fresh mouse serum, respectively, for 30 min at 37°C.
Thereafter, 5 x 10" lymphocytes were added to the mixtures and
incubation continued for 30 min. The cells were washed and rosetted
with SRBC treated to reveal Fc or C'3 binding lymphocytes.
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Treatment oflymphocytes*
RFC
Fe
binding
C'3
Fresh serum plus BSS 23 14
LPSplus BSS 32 25
LPSplus inactivated serum 23 27
LPSplus fresh serum 19 2656
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the Ig receptors . However, the Ig receptors can decrease the optimally stimulat-
ing concentration of a PBA by a factor of 10 3-106 , whereas C'3 receptors only
caused a 10- to 100-fold difference in the optimal concentrations . This most likely
reflects the relative affinities of the. binding to the two types of receptors
involved .
Fc Receptors do not Actiuate Lymphocytes .
￿
Two approaches were used to
investigate whether binding to Fc receptors would activate lymphocytes to
polyclonal antibody synthesis . In the first, SRBC were coated with two
concentrations (1/100 and 1/1,000) of the 7S fraction of a rabbit anti-SRBC
serum . Subsequently, the washed red cells were mixedwith spleen cells as in the
procedure for the detection of Fe-binding lymphocytes, the mixture was
centrifuged and resuspended, and thereafter cultivated in serum-free medium .
Polyclonal antibody responses were determined 2 days later . As can be seen in
Fig . 7 there was no evidence for induction of polyclonal antibody synthesis, nor
FIG. 7 .
￿
Failure of Fe receptors to induce polyclonal antibody synthesis or to suppress such
responses induced by LPS. Serum-free cultures were set up without addition to medium
(controls) or with 100 fag LPS (LPS treated) . Before culture the lymphocytes were untreated
(1), treated withSRBC (2), with SRBC sensitized with a 1/100 (3) or 1/1,000 (4) dilution of 7S
anti-SRBC serum or treated with the antiserum diluted 1/100 alone (5) . Untreated lympho-
cytes were givenLPS in culture (6) as were cells rosetted with antiserum diluted 1/100 (7) and
1/1,000 (8) . The response against FITC was determined at day 2 .
was there an increased number of PFC detectable against the antigen (SRBC)
added to the cultures (Fig . 8) . Thus, the Fc receptors did not appear to activate
lymphocytes into polyclonal or specific antibody synthesis.
In order to study whether occupied Fc receptors would interfere with polyclonal
activation-induced PBA, the rosetted lymphocytes were treated with LPS or
PPD at optimal concentrations in serum-free medium . There was no indication
of suppression of polyclonal antibody synthesis (Fig . 7) nor was the LPS-induced
response to SRBC in the presence of Fc-coated SRBC significantly changed as
compared to non-SRBC-treated controls (Fig . 8) .
In the second system, a highly thymus-dependent antigen (FITC,.-HGG) was
employed in conjugation with a specific anti-FITC-HGGserum or the 7S fraction
of this serum . It was first studied whether an antigen antibody complex of this
type would adhere to lymphocytes as has been reported by others (1, 10, 11) .GORAN MOLLER AND ANTONIO COUTINHO
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FIG. 8.
￿
Same as Fig. 7, but measuring specific anti-SRBC responses .
FITC,o-HGG at a concentration of 250 or 25 yg/ml was mixed with various
concentrations (1/2 to 1/16) of the antiserum or the 7S fraction of it . After 30 min
at 37 °C 106 spleen cells were added to the mixture, which was incubated for 30
min . After washings the cells were inspected in a fluorescent microscope . It was
found that between 39-50% of the cells had bound fluorescent material in all the
mixtures tested, although the intensity of the binding decreased with decreasing
antigen concentrations . There was no difference between unfractionated serum
and the 7S fraction . When antiserum was replaced with normal serum there was
no detectable binding to any cells . Thus, the antigen-antibody complexes used
bound to lymphocytes, most likely to the Fc receptors on B cells as described by
others (1, 10, 11) .
In order to study whether such antigen-antibody complexes would by
themselves activate lymphocytes into polyclonal antibody synthesis or prevent
activation by competent ligands, several different types of experiments were
carried out. FITC,,,-HGG in concentrations ranging from 25 to 0.0025 Ag/ml were
added to cultures which also received antiserum or the 7S fraction of the
antiserum in concentrations ranging from 1/10 to 1/10,000 . In the controls normal
mouse serum or the 7S fraction from normal serum replaced the antiserum . In
addition, the antigen alone or the antiserum alone was used in various
concentrations . Alternatively, immune complexes were first formed in vivo by
incubation for 30 min at 37°C and thereafter they were added in different
concentrations to serum-free spleen cell cultures . The polyclonal response
(against SRBC) was measured at day 2 or 4 . In addition, the anti-FITC response
was measured at the same time periods . As shown in Table III, there was no
induction of antibody synthesis. Quite often the background increased, but this
was observed to the same extent in cultures given normal serum, or antibody
alone and most likely represented a serum effect . High concentrations of antigen
was often suppressive as seen before with this antigen (28) . The experimental
conditions covered 10"-fold concentrations of antigen and antibody, respectively,
but there was no induction of polyclonal antibody or specific antibody synthesis .
These complexes did not interfere to any significant extent with the ability of
LPS to induce polyclonal antibody synthesis as shown in Table III and Fig. 9 and658
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TABLE III
Effect of Antigen-Antibody Complexes on Induction of Antibody Synthesis
* The antigen and the antibody were added separately to the cultures . The response measured at day 2 against
FITC-SRBC and is expressed as PFC/10° cells .
Complexes were formed in vitro and added to the cultures . The response measured at day 2 against FITC-SRBC .
§ After complexes had been formed, fresh mouse serum was added as a source of complement and the mixture
added to the cultures .
10, except in high concentration . However, the background PFC response was
suppressed to a comparable extent, indicating that the effect was caused by
nonspecific toxicity, as observed before (28) .
The Simultaneous Binding to Fc and C'3 Does Not Trigger Antibody
Synthesis . To study whether the simultaneous binding to Fe and C'3 receptors
would initiate antibody synthesis, antigen-antibody complexes between FITCto-
HGG and the corresponding antibody were first formed in vitro and subsequently
fresh mouse serum was added as a source of complement . These complexes were
added to serum-free cultures of spleen cells . Controls included complexes alone,
complexes with heat-inactivated mouse serum, only fresh and inactivated serum
(Table III) . There was no induction of polyclonal or anti-FITC antibody with any
Antigen preparations added
-
PFC response in the presence ofthe following concentrations of:
IgG anti-FITC-HGG IgG from normal serum
1/10 1/1oo 1/1,000 1/10,ooo - 1/10 1/1oo 1/1,000 1/10,000
ag/m l
- 23 38 32 29 28 23 50 19 28 17
FITC, a-HGG* 25 8 28 6 5 5 31 4 7 5
2.5 12 16 18 9 5 25 5 5 9
0.25 6 61 30 13 7 27 21 16 5
0.025 7 44 21 18 10 35 21 15 12
LPS 100 510 510
- 27 27
FITC,o-HGG + IgG 25 9 0
anti-FITC-HGG$ 2 .5 11 8
0.25 15 15
0.025 14 39
FITC,o-HGG + IgG 25 8 0
anti-FITC-HGG + 2 .5 36 11
NS§ 0.25 15 18
0.025 20 12
LPS
-
471
60
471
PFC response in
1001/g
896
the presenceof
LPS
FITC,o-HGG + IgG 25 72 513
anti-FITC-HGG$ 2 .5 75 136 491 888
0.25 110 48 834 884
0.025 66 881
FITC-HGG + IgG 25 104 551
anti-FITC-HGG + 2 .5 75 141 251 1072
NS§ 0.25 48 81 1032 798
0.025 48 669x
N
J
W 5
U
O
V
a
x
J
J
W
U
0
U
a
0
5
0
GORAN MOLLER AND ANTONIO COUTINHO
￿
659
15
10
0
e
a
G
e
X
0
￿
" 0.025
￿
0.25
￿
2.5
￿
25
CONCENTRATION OF FITC10HGG (pg/ml)
FIG . 9.
￿
Failure of antigen-antibody complexes to induce polyclonal antibody synthesis or suppress
the response to LPS . Complexes of 250 gg (0) or 25 ug (") of FITC,o-HGG and the 7S fraction of
mouse anti-FITC, u-HGG were formed in vitro . Thereafter different concentrations of the complexes
were added to cultures (
￿
) . The same complexes were also added to cultures given 100 jug LPS
( . . . . ) . One complex wasincubatedwith fresh mouse serum asasource of complement andthereafter
added to cultures (x) . The background (A) as well as the response to LPS itself is also shown (O).
Q
X
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FIG. 10 .
￿
Same as Fig. 9, using anotherbatch of antigen and a different antiserum.
complexes . Thus, the simultaneous binding to both Fc and C'3 receptors cannot
activate lymphocytes .
Discussion
It has been established that polyclonal antibody synthesis can be induced by
PBA acting on nonspecific receptor(s) . The evidence strongly suggests also that
specific antibody synthesis is induced by one nonspecific signal identical to that
activating cells polyclonally (5, 7, S, 9) . Thus, specific thymus-independent
antibody synthesis is induced by antigenic determinants coupled to PBA
molecules, but only under conditions that allow expression of thePBA property .
Hapten-LPS conjugates are capable of inducing specific antihapten responses
only if the LPS molecule is a PBA, but not if it has been chemically modified so660
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as to lose PBA properties (alcaline hydrolysis), even though the hapten density
was the same in the two preparations (17) . Also, hapten-LPS conjugates are not
immunogenic in mice which are genetically unresponsive to the PBA property of
LPS, whereas a normal response can be obtained in these mice against the same
hapten coupled to other PBA carriers or to TD antigens (6, 8, 33, 35, footnotes 3
and 4) . These findings exclude any triggering mechanism based only on interac-
tion with the Ig receptors (e.g. cross-linking) as the activating event. In a recent
report (15) it has been claimed that insolubilized antigen is capable of achieving
triggering of B cells into specific antibody synthesis. The experiments made use
of hapten-KLH conjugates coupled to Sepharose beads. Since KLH has been
shown to be a PBA (8) it is to be expected that a hapten conjugated to KLH
would be immunogenic and the observed difference between soluble and
insolubilized conjugates is not unexpected (for discussion see 8), since KLH is a
weak PBA which may require both Ig focussing and high local concentrations if
the experimental conditions are unfavorable (e.g. carried out in the presence of
serum) . It is noteworthy that the direct test of the hypothesis put forward
(cross-linking of Ig receptor causes B-cell triggering), namely the insolubilization
of the hapten directly to Sepharose beads (without the presence of theweak PBA
protein carrier), was not carried out. Instead the experiments were performed
with a completely different insoluble matrix (polyacrylamid) . However, it is
known that polyacrylic acid is capable of interacting with the PBAreceptors (8).
The two-signal model (3) of B-cell activation is made highly unlikely by several
findings (for discussion see 8) . Thus, PBA induces antibody response even though
there is no complementarity between the PBA and the combining site of the Ig
receptors (7) . The specific antihapten response to a hapten conjugated to a PBA
is abolished by the simultaneous addition of free hapten (5), although the
two-signal hypothesis would not predict that . The hapten-blocked cells are not
paralyzed, however, since high concentrations of the hapten-PBA conjugate
induce antihapten responses (5). Finally, all attempts but one (36) to induce
specific antihapten responses by hapten-completely TD antigen complexes
(signal one) together with PBA 8 (signal 2) have failed (7, 27). Synergy between
antigen and PBA has been observed repeatedly, but the positive reports have
been carried out in vivo (8, 33, footnote 5) or else in vitro with red cell antigens
(20, 31, 32). In the latter case it has been shown that theeffect depends on helper
cells (T cells and adherent cells) and does not represent a direct effect on B cells
(20) . It is obviously necessary to establish that two substances act on the same B
cells in order to substantiate a two-signal concept, but so far this has not been
performed. Thus, the synergy experiments performed do notsupport a two-signal
hypothesis. Actually, they argue against this conceptwhen considered together .
Presently, only the one-signal hypothesis (9) can explain the experimental
findings in a satisfactory way. This concept postulates the existance of a
nonspecific triggering receptor. It is therefore essential to identify the nature of
this receptor . This paper represents such an attempt and attention was focussed
on two well characterized receptors, namely the Fc and C'3 receptor . Both have
s Persson, U., and E. Moller. The effect of LPS on the primary immune response against the
hapten NNP. Manuscript submitted for publication.GORAN MOLLER AND ANTONIO COUTINHO
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been implicated as triggering receptors. It was initially claimed that the C'3
receptor was the actual triggering receptor (13), but recent findings make this
unlikely and it is presently suggested that these receptors only have a function in
TD responses, and this function is not believed to directly trigger B cells but
rather to increase the binding of the antigen to the B cells (12, 13, 16, 18, 30).
The studies presented above exclude C'3 receptors as direct triggering
receptors, but. support the notion that C'3 receptors may have a focussing
function, allowing a more efficient binding to B cells of substances that have
bound C'3. This may makethe triggering event moreefficient when the antigen is
TI, since lower concentrations of PBA aresufficient for optimal triggering. It also
allows paralysis to be induced at lower concentrations. An analogous role of C'3
may operate in TD responses. However, in comparison with the focussing
function oftheIg receptors, the C'3 receptors are inefficient and probably they do
not play a major role in immunogenicity.
Fc receptors have also been suggested to play an essential role in lymphocyte
activation. This was initially based on the findings that antigen-antibody
complexes were competent to induce DNA synthesis in blood lymphocytes (26).
Furthermore, the Fe receptors (21, 23, 29) are responsible for induction of
antibody-induced, lymphocyte-mediated cytotoxicity (25), even though the
nature of the activated cells (non-T) remains obscure. Finally, the findings that
la antigens appear to be physically linked on the cell membrane to the Fc
receptors (11), since anti-la antiserum prevents binding of Fc to the B cells (11)
and that the same antiserum have the ability to suppress at least some
immunological recognition phenomena, such as the MLC reaction (14), have
focussed interest on the possible triggering role ofthe Fc (or Ia) structures. The
findings in this paper do,support the notion that Fc receptors are competent to
trigger B cells directly, not the idea that the Fc receptors constitute part of the
triggering sites, since blocked Fc receptors failed to influence polyclonal and
specific induction by PBA. Again, the Fe receptors may have a passive focussing
function by attracting competent ligands which have bound antibody to the
surface in a higher concentration than could otherwise be achieved, but this role
is probably ofminor importance. The nature of the nonspecific B-cell triggering
structure responsible for induction of antibody synthesis is still unknown.
Summary
Attempts were made to identify the non-Ig lymphocyte receptor responsible for
B-cell induction by antigen and polyclonal B-cell activators (PBA). As a first
step, the role of C'3 and Fc receptors was analyzed. It was shown that
complement could be fixed onto B cells to such an extent that the lymphocytes
could not bind complement-coated red cells, but this did not result in induction
of polyclonal antibody synthesis, nor did it inhibit the lymphocytes response to
PBA.
However, the C'3 receptors possessed a passive focussing role in the induction
of polyclonal antibody responses. Thus, PBA that had fixed complement acti-
vated polyclonal responses at lower concentrations than the same substances
that had not fixed complement. Most likely the dual bindingofPBA molecules to
B cells by the PBA and the C'3 receptors caused more PBA molecules to be662
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bound to each cell . However, the focussing function of the C'3 receptors was sev-
eral orders of magnitude smaller than that of the Ig receptors .
Analogous studies were carried out with Fc receptors . Binding of different
types of antigen-antibody complexes did not cause activation of polyclonal or
specific antibody synthesis, nor did it significantly interfere with induction of
antibody synthesis by PBA substances .
The technical assistance of Miss Lena Lundin is gratefully acknowledged .
Received for publication 26 November 1974 .
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